AbbVie vs Broadcom: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Broadcom was founded in 1991 by Henry Samueli, Henry Nicholas III and is led by Hock Tan.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Broadcom
Henry Samueli
Henry Samueli co-founded Broadcom Corporation in Los Angeles in 1991 with Henry Nicholas III, his former doctoral student, and served as its chief technical officer while the company built chips for cable modems, set-top boxes, Ethernet and Wi-Fi.
Henry Nicholas III
Henry Nicholas III co-founded Broadcom Corporation with Samueli in 1991 and was its president and CEO through the cable modem boom, the April 1998 IPO and a string of stock-funded acquisitions in 1999 and 2000. He resigned in January 2003.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Broadcom
- Henry Samueli1991–present
Co-Founder and Chairman of the Board
Henry Samueli co-founded Broadcom Corporation in 1991 and, as chief technical officer, led the engineering behind its cable modem, Ethernet and Wi-Fi chips. He joined the board after Avago bought Broadcom Corporation in 2016 and is chairman of Broadcom Inc.
Source - Henry Nicholas III1991–2003
Co-Founder; President and CEO of Broadcom Corporation
Henry Nicholas III ran Broadcom Corporation from its founding through its April 1998 IPO and the dot-com boom, then resigned in January 2003. Backdating and drug charges brought against him in 2008 were dismissed in December 2009 and January 2010.
Source - Scott McGregor2005–2016
President and CEO of Broadcom Corporation
Scott McGregor led Broadcom Corporation from 2005 until Avago completed its $37 billion acquisition in February 2016, a period when the company expanded in Wi-Fi, Bluetooth, set-top box and data center switch chips.
Source - Hock Tan2006–present
President and Chief Executive Officer
Hock E. Tan became CEO of Avago Technologies in March 2006 and has run the company through its acquisitions of LSI (2014), Broadcom Corporation (2016), Brocade (2017), CA Technologies (2018), Symantec's enterprise business (2019) and VMware (2023).
Source - Kirsten Spears2020–2026
Chief Financial Officer
Kirsten Spears was CFO for about six years of her 12 years at Broadcom, covering the VMware financing and the AI-driven growth of 2024 and 2025. She retired on 12 June 2026 and agreed to advise the company for nine months.
Source - Amie Thuener2026–present
Chief Financial Officer
Amie Thuener joined Broadcom as CFO on 12 June 2026 from Alphabet, where she had been vice president, corporate controller and chief accounting officer since 2018, after an earlier career at PricewaterhouseCoopers.
Source
Timeline: AbbVie and Broadcom side by side
1991Broadcom
Broadcom Corporation founded
UCLA professor Henry Samueli and his former doctoral student Henry Nicholas III found Broadcom Corporation in Los Angeles to build broadband communications chips in CMOS, starting with chips for cable modems and digital set-top boxes.
1998Broadcom
Broadcom Corporation IPO
Broadcom Corporation lists on Nasdaq in April 1998 at $24 a share, as cable operators roll out DOCSIS cable modems built on its chips.
2005Broadcom
Avago Technologies formed
KKR and Silver Lake buy Agilent Technologies' semiconductor products group, whose roots go back to Hewlett-Packard's chip operations, for about $2.66 billion and name it Avago Technologies.
2006Broadcom
Hock Tan becomes CEO of Avago
Hock Tan becomes president and CEO of Avago in March 2006 and begins pruning its portfolio to the businesses with defensible technology.
2009Broadcom
Avago lists on Nasdaq
Avago Technologies goes public on Nasdaq in August 2009 at $15 a share, giving it stock to use in later acquisitions.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014Broadcom
LSI Corporation acquired
Avago completes its $6.6 billion purchase of LSI in May 2014, adding storage controllers and custom ASIC design teams.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016Broadcom
Avago buys Broadcom Corporation
Avago completes its $37 billion acquisition of Broadcom Corporation in February 2016, takes the Broadcom name and trades as AVGO.
2017Broadcom
Brocade acquired
Broadcom completes its $5.9 billion purchase of Brocade Communications in November 2017, adding Fibre Channel storage networking switches.
2018Broadcom
Qualcomm bid blocked and move to the U.S.
President Trump blocks Broadcom's unsolicited bid for Qualcomm on national security grounds in March 2018. Broadcom completes its redomicile from Singapore to the United States that April.
2018Broadcom
CA Technologies acquired
Broadcom completes its $18.9 billion purchase of CA Technologies in November 2018, its first large software deal, creating the infrastructure software segment.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2019Broadcom
Symantec enterprise security acquired
Broadcom buys Symantec's enterprise security business for $10.7 billion in November 2019, adding endpoint, web and data loss prevention software.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2022Broadcom
VMware deal announced
Broadcom agrees in May 2022 to buy VMware in a cash-and-stock deal valued at about $61 billion at announcement.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Broadcom
VMware acquisition closes
Broadcom completes the VMware acquisition on 22 November 2023 after clearances in the U.S., EU, UK and China, a deal valued at about $69 billion including assumed debt.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Broadcom
Stock split and $1 trillion market value
Broadcom splits its stock 10-for-1 in July 2024, sells VMware's end-user computing unit to KKR for about $4 billion, reports fiscal 2024 revenue of $51.6 billion and passes $1 trillion in market value in December 2024.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Broadcom
OpenAI partnership and record fiscal 2025
OpenAI and Broadcom agree in October 2025 to deploy 10 gigawatts of OpenAI-designed accelerators. Fiscal 2025 revenue rises 24% to $63.9 billion, with about $20 billion from AI chips.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Broadcom
AI chips pass half of revenue
Amie Thuener becomes CFO in June 2026. Third-quarter fiscal 2026 revenue rises 86% to $29.6 billion, and AI semiconductor revenue of $16.7 billion is 56% of the total.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Broadcom
- VMware2023$69B
- Symantec Enterprise Security business2019$10.7B
- CA Technologies2018$18.9B
- Brocade Communications Systems2017$5.9B
- Broadcom Corporation2016$37B
- LSI Corporation2014$6.6B
Questions about AbbVie vs Broadcom
Who is the CEO of AbbVie Inc. and Broadcom Inc.?
AbbVie Inc. is led by Robert A. Michael and Broadcom Inc. is led by Hock Tan. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Broadcom Inc.?
Broadcom Inc. was founded in 1991 — 22 years before AbbVie Inc., which was founded in 2013. Broadcom Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Broadcom Inc.?
AbbVie Inc. employs approximately 57,000 people, while Broadcom Inc. employs approximately 33,000. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Broadcom Inc.'s 33,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Broadcom Inc. headquartered?
Both AbbVie Inc. and Broadcom Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Broadcom Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Broadcom Inc. was founded by Henry Samueli, Henry Nicholas III.
Which company has a longer operating history — AbbVie Inc. or Broadcom Inc.?
Broadcom Inc. has been operating for approximately 35 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Broadcom overview